Loading clinical trials...
Loading clinical trials...
A Phase 3, Multicenter, Randomized, Double-Masked, Controlled Study of Squalamine Lactate (MSI-1256F) for Injection for the Treatment of Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration
Conditions
Interventions
Squalamine Lactate
Locations
29
United States
Retina-Vitreous Associates Medical Group
Beverly Hills, California, United States
Eldorado Retina Associates
Louisville, Colorado, United States
Florida Eye Microsurgical Institute
Boynton Beach, Florida, United States
National Ophthalmic Research Institute
Fort Myers, Florida, United States
University of Florida
Jacksonville, Florida, United States
Magruder Eye Institute
Orlando, Florida, United States
Start Date
June 1, 2005
Last Updated
November 28, 2007
Lead Sponsor
Genaera Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions